[Industry Voice #20] Roche on RWE: shifting the landscape of clinical research and healthcare

Real-World Evidence has been used to speed access to new treatment options, especially for rare diseases, and served as a resource to better characterize treatment effects, including those in underrepresented populations. In this episode of Industry Voice our guest, Galina Osina, RWE Lead at Roche will help us analyze the ongoing and future trends of Real-World Data in pharmaceutical research.
Enjoy and subscribe to our TH-cam channel to be the first to know about new content on clinical research.
0:00 Introduction
0:18 Why is RWE a hot topic today?
2:30 Main trends in the Real World Data area
5:28 The importance of the reference points for RWE
Enjoy and subscribe to our TH-cam channel to be the first to know about new content on clinical research.
Webpage: oct-clinicaltrials.com/.
Experience: oct-clinicaltrials.com/oct-ex....
Blog, articles, case studies: oct-clinicaltrials.com/resources.
LinkedIn: / oct-clinical-trials-in...
✉Reach out to become the next speaker: [e-mail]
✉Submit an RFP for clinical services: [e-mail]
#Roche #RWE #clinicalresearch #industryvoice #octclinical #RochePharma

[@charleneterrell]

This is not the platform to fully discuss my plans, but in simplest terms research leads to new developments in pharma.

[@user-wf5io5ec9f]

С интересом смотрю интервью/ хотелось бы побольше именно про технологии будущего и виар в медицине// и на русском//